Clinical Trial Detail

NCT ID NCT03557918
Title Trial of Tremelimumab in Patients With Previously Treated Metastatic Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Matthew Galsky
Indications

urethra transitional cell carcinoma

ureter transitional cell carcinoma

renal pelvis transitional cell carcinoma

bladder urothelial carcinoma

Therapies

Tremelimumab

Age Groups: adult senior

No variant requirements are available.